{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:29:20Z","timestamp":1787761760632,"version":"build-2784847793"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100002597","name":"American Physicians Fellowship for Medicine in Israel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002597","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023801","name":"Association of Fundraising Professionals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017556","name":"Memorial Sloan Kettering Cancer Center Marie-Jos\u00e9e and Henry R Kravis Center for Molecular Oncology","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100017556","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.modpat.2024.100616","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T02:27:49Z","timestamp":1727144869000},"page":"100616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma"],"prefix":"10.1016","volume":"38","author":[{"given":"Benzion","family":"Samueli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Sarungbam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson W.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-6969","authenticated-orcid":false,"given":"Jie-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.modpat.2024.100616_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0230-6","article-title":"The cancer driver genes IDH1\/2, JARID1C\/KDM5C, and UTX\/KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism","volume":"51","author":"Chang","year":"2019","journal-title":"Exp Mol Med"},{"issue":"19","key":"10.1016\/j.modpat.2024.100616_bib2","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.1182\/bloodadvances.2022008282","article-title":"Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis","volume":"7","author":"Zarnegar-Lumley","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.modpat.2024.100616_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.20937","article-title":"IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors","volume":"30","author":"Bleeker","year":"2009","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","article-title":"Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers","volume":"125","author":"Kang","year":"2009","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nbt.3391","article-title":"Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity","volume":"34","author":"Chang","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/2159-8290.CD-17-0321","article-title":"Accelerating discovery of functional mutant alleles in cancer","volume":"8","author":"Chang","year":"2018","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"issue":"7637","key":"10.1016\/j.modpat.2024.100616_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nature20788","article-title":"Genomic hallmarks of localized, non-indolent prostate cancer","volume":"541","author":"Fraser","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.modpat.2024.100616_bib9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.modpat.2024.100616_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00345-018-2225-7","article-title":"Immunohistochemically detected IDH1(R132H) mutation is rare and mostly heterogeneous in prostate cancer","volume":"36","author":"Hinsch","year":"2018","journal-title":"World J Urol"},{"issue":"6","key":"10.1016\/j.modpat.2024.100616_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100146","article-title":"Highly recurrent IDH1 mutations in prostate cancer with psammomatous calcification","volume":"36","author":"Mehra","year":"2023","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100616_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pathol.2023.06.017","article-title":"IDH1\u00a0p.R132C mutation in prostatic carcinoma with psammomatous calcifications: report of two cases","volume":"56","author":"Galea","year":"2024","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib13","first-page":"152","article-title":"Distribution and significance of microcalcifications in the neoplastic and nonneoplastic prostate","volume":"122","author":"Woods","year":"1998","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.modpat.2024.100616_bib14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anndiagpath.2007.07.001","article-title":"Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens","volume":"12","author":"Suh","year":"2008","journal-title":"Ann Diagn Pathol"},{"issue":"23","key":"10.1016\/j.modpat.2024.100616_bib15","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7406","key":"10.1016\/j.modpat.2024.100616_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm.4053","article-title":"Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer","volume":"22","author":"Kumar","year":"2016","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib18","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cell.2015.06.053","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"162","author":"Robinson","year":"2015","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.modpat.2024.100616_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"10.1016\/j.modpat.2024.100616_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","article-title":"An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics","volume":"173","author":"Liu","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.modpat.2024.100616_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"issue":"6","key":"10.1016\/j.modpat.2024.100616_bib23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.modpat.2024.100616_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.modpat.2024.100616_bib25","doi-asserted-by":"crossref","DOI":"10.1200\/PO.17.00084","article-title":"Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data","author":"Middha","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100616_bib26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.modpat.2024.100616_bib27","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.18632\/oncotarget.13918","article-title":"Performance evaluation for rapid detection of pan-cancer microsatellite instability with MANTIS","volume":"8","author":"Kautto","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.modpat.2024.100616_bib28","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1158\/1078-0432.CCR-14-2666","article-title":"Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer","volume":"21","author":"Azad","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2024.100616_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13059-015-0864-1","article-title":"Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients","volume":"17","author":"Lallous","year":"2016","journal-title":"Genome Biol"},{"issue":"312","key":"10.1016\/j.modpat.2024.100616_bib30","doi-asserted-by":"crossref","first-page":"312re10","DOI":"10.1126\/scitranslmed.aac9511","article-title":"Plasma AR and abiraterone-resistant prostate cancer","volume":"7","author":"Romanel","year":"2015","journal-title":"Sci Transl Med"},{"issue":"8","key":"10.1016\/j.modpat.2024.100616_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.modpat.2024.100616_bib32","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/ijc.24647","article-title":"Absence of IDH2 codon 172 mutation in common human cancers","volume":"125","author":"Park","year":"2009","journal-title":"Int J Cancer"},{"issue":"33","key":"10.1016\/j.modpat.2024.100616_bib33","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1038\/onc.2011.546","article-title":"IDH mutation status in prostate cancer","volume":"31","author":"Ghiam","year":"2012","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/PAI.0b013e3182649d1c","article-title":"Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas","volume":"22","author":"Mauzo","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.neo.2015.03.004","article-title":"Development and validation of a scalable next-generation sequencing system for assessing relevant somatic variants in solid tumors","volume":"17","author":"Hovelson","year":"2015","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1078-0432.CCR-16-1454","article-title":"Molecular profiling to determine clonality of serial magnetic resonance imaging\/ultrasound fusion biopsies from men on active surveillance for low-risk prostate cancer","volume":"23","author":"Palapattu","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neo.2017.12.001","article-title":"IDH1R132H promotes malignant transformation of benign prostatic epithelium by dysregulating microRNAs: involvement of IGF1R-AKT\/STAT3 signaling pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.modpat.2024.100616_bib38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","article-title":"The DNA methylation landscape of advanced prostate cancer","volume":"52","author":"Zhao","year":"2020","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.modpat.2024.100616_bib39","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cbin.12000","article-title":"Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis","volume":"47","author":"Montero-Ovalle","year":"2023","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.modpat.2024.100616_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.09.013","article-title":"Molecular epidemiology of IDH2 hotspot mutations in cancer and immunohistochemical detection of R172K, R172G, and R172M variants","volume":"106","author":"Dogan","year":"2020","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100616_bib41","first-page":"514","article-title":"Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features","volume":"8","author":"Maruyama","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"17","key":"10.1016\/j.modpat.2024.100616_bib42","first-page":"6395","article-title":"Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features","volume":"9","author":"Sathyanarayana","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.modpat.2024.100616_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOU.0000000000000285","article-title":"Molecular subtyping of prostate cancer","volume":"26","author":"Kaffenberger","year":"2016","journal-title":"Curr Opin Urol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100616_bib44","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1158\/1541-7786.MCR-19-0020","article-title":"Reprogramming of isocitrate dehydrogenases expression and activity by the androgen receptor in prostate cancer","volume":"17","author":"Gonthier","year":"2019","journal-title":"Mol Cancer Res"},{"issue":"10","key":"10.1016\/j.modpat.2024.100616_bib45","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/1878-0261.13441","article-title":"Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer","volume":"17","author":"Gonthier","year":"2023","journal-title":"Mol Oncol"},{"issue":"39","key":"10.1016\/j.modpat.2024.100616_bib46","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-020-01429-2","article-title":"Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing","volume":"39","author":"Shah","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.modpat.2024.100616_bib47","article-title":"Integrative multiomics evaluation of IIDH1 metabolic enzyme as a candidate oncogene that is correlated with poor prognosis and immune infiltration in prostate adenocarcinoma","volume":"2022","author":"Wen","year":"2022","journal-title":"J\u00a0Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100616_bib48","doi-asserted-by":"crossref","first-page":"13398","DOI":"10.1096\/fj.201901366R","article-title":"IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1alpha-regulated pseudohypoxic state","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.modpat.2024.100616_bib49","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3892\/ijo.2015.2855","article-title":"Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer","volume":"46","author":"Kluth","year":"2015","journal-title":"Int J Oncol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224001960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T02:37:46Z","timestamp":1767235066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224001960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0893395224001960"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100616","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histopathologic and Molecular Characterization of IDH-Mutant Prostatic Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100616","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100616"}}